Shiga, Japan

Yoshiyuki Hayashi


Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Shiga, JP (1990 - 1991)
  • Kusatsu, JP (1990 - 1994)

Company Filing History:


Years Active: 1990-1994

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Yoshiyuki Hayashi

Introduction

Yoshiyuki Hayashi is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and antibiotics. With a total of 4 patents to his name, Hayashi's work has had a considerable impact on medical science.

Latest Patents

One of his latest patents is related to a recombinant avipoxvirus. This recombinant Avipoxvirus has inserted all or a part of cDNA coding for Newcastle disease virus-derived hemagglutinin neuraminidase in a genome region non-essential to the proliferation of Avipoxvirus. This innovation is particularly useful as a vaccine for fowl. Another significant patent is for the glycopeptide antibiotic PA-45052-B. This antibiotic, produced by Nocardia orientalis PA-45052, shows potent activity against gram-positive bacteria, especially against methicillin-resistant bacteria, and stimulates the growth of animals.

Career Highlights

Throughout his career, Yoshiyuki Hayashi has worked with prominent companies such as Shionogi Company Limited and Nippon Zeon Company, Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Hayashi has collaborated with notable coworkers, including Takao Konishi and Eiji Kondo. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Yoshiyuki Hayashi's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…